A high-throughput and modular screening platform to optimize CAR designs for oncology and autoimmunity
Conferences
McCutcheon, S; Berry, S; Bohning, J; Savoldo, B; Dotti, G; Gersbach, C; Black, J
Published in: MOLECULAR THERAPY
May 8, 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
May 8, 2026
Volume
34
Issue
5
Start / End Page
30 / 33
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
McCutcheon, S., Berry, S., Bohning, J., Savoldo, B., Dotti, G., Gersbach, C., & Black, J. (2026). A high-throughput and modular screening platform to optimize CAR designs for oncology and autoimmunity. In MOLECULAR THERAPY (Vol. 34, pp. 30–33).
McCutcheon, Sean, Shante Berry, Joel Bohning, Barbara Savoldo, Gianpietro Dotti, Charles Gersbach, and Joshua Black. “A high-throughput and modular screening platform to optimize CAR designs for oncology and autoimmunity.” In MOLECULAR THERAPY, 34:30–33, 2026.
McCutcheon S, Berry S, Bohning J, Savoldo B, Dotti G, Gersbach C, et al. A high-throughput and modular screening platform to optimize CAR designs for oncology and autoimmunity. In: MOLECULAR THERAPY. 2026. p. 30–3.
McCutcheon, Sean, et al. “A high-throughput and modular screening platform to optimize CAR designs for oncology and autoimmunity.” MOLECULAR THERAPY, vol. 34, no. 5, 2026, pp. 30–33.
McCutcheon S, Berry S, Bohning J, Savoldo B, Dotti G, Gersbach C, Black J. A high-throughput and modular screening platform to optimize CAR designs for oncology and autoimmunity. MOLECULAR THERAPY. 2026. p. 30–33.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
May 8, 2026
Volume
34
Issue
5
Start / End Page
30 / 33
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics